Elective oocyte freezing for the preservation of fertility

Jason Barritt, Martha Luna, Benjamin Sandler, Marlena Duke, Alan B. Copperman

Reproductive Endocrinology, Mount Sinai School of Medicine, New York, USA.
Reproductive Medicine Associates of New York, New York, USA.

DOI: 10.4236/ojog.2012.21005                

Abstract

Oocyte cryopreservation has recently emerged as an option for women to preserve their fertility for medical (e.g. treatable malignancy) or elective indications (e.g. advancing age). This report describes an IRB-approved study of over 200 oocyte cryopreservation cycles at one center. Patients presenting for oocyte cryopreservation (January 2005 to 2010) were analyzed for day 3 follicle stimulating hormone (FSH), basal antral follicle count (BAFC), gonadotropin usage and the number of oocytes retrieved and cryopreserved. New patient consultations were performed on 516 women, of whom 175 (34%) proceeded to initiate a total of 233 cryopreservation cycles. Twenty-four cycles were cancelled (10%) after starting follicular stimulation due to poor ovarian response or self-withdrawal of the patients. Patients whose cycles were cancelled demonstrated a higher Day 3 FSH and a lower BAFC than patients who completed cycles (p < 0.01). In the 209 completed cycles, the most important predictors of a successful cycle included BAFC (r = 0.36), FSH (r = –0.25) and age (r = –0.18) with the mean number of oocytes cryopreserved at 13.6 ± 8.8. Information about long-term fertility preservation must reach both patients and health care providers so that more women can be educated about the benefits of proactive early physiological reproductive assessment and possible interventions available.

Keywords

Human Oocyte Cryopreservation; Fertility Preservation; Oocyte Aging; Ovarian Reserve; Follicle Stimulating Hormone; Basal Antral Follicle Count

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Chen, C. (1986) Pregnancy after human oocyte cryopreservation. Lancet, 1, 884-886. doi:10.1016/S0140-6736(86)90989-X
[2]	Gook, D.A., Osborn, S.M. and Johnston, W.I. (1993) Cryopreservation of mouse and human oocytes using 1, 2-propanediol and the configuration of the meiotic spindle. Human Reproduction, 8, 1101-1109.
[3]	Gook, D.A., Osborn, S.M., Bourne, H. and Johnston, W.I. (1994) Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosomes. Human Reproduction, 9, 684-691.
[4]	Gook, D.A., Schiewe, M.C., Osborn, S.M., Asch, R.H., Jansen, R.P. and Johnston, W.I. (1995) Intracytoplasmic sperm injection and embryo development of human oocytes cryopreserved using 1,2-propanediol. Human Reproduction, 10, 2637-2641.
[5]	Fineschi, V., Neri, M. and Turillazzi, E. (2005) The new Italian law on assisted reproduction technology (Law 40/2004). Journal of Medical Ethics, 31, 536-539. doi:10.1136/jme.2004.010231
[6]	Porcu, E., Fabbri, R., Seracchioli, R., Ciotti, P.M., Magrini, O. and Flamigni, C. (1997) Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertility and Sterility, 68, 724-726. doi:10.1016/S0015-0282(97)00268-9
[7]	Porcu, E., Fabbri, R., Damiano, G., Giunchi, S., Fratto, R., Ciotti, P.M., et al. (2000) Clinical experience and applications of oocyte cryopreservation. Molecular and Cellular Endocrinology, 169, 33-37. doi:10.1016/S0303-7207(00)00348-8
[8]	Fosas, N., Marina, F., Torres, P.J., Jové, I., Martín, P., Pérez, N., et al. (2003) The births of five Spanish babies from cryopreserved donated oocytes. Human Reproduction, 18, 1417-1421. doi:10.1093/humrep/deg297
[9]	Bianchi, V., Coticchio, G., Fava, L., Flamigni, C. and Borini, A. (2005) Meiotic spindle imaging in human oocytes frozen with a slow freezing procedure involving high sucrose concentration. Human Reproduction, 20, 1078-1083. doi:10.1093/humrep/deh736
[10]	Nottola, S.A., Coticchio, G., De Santis, L., Macchiarelli, G., Maione, M., Bianchi, S., et al. (2008) Ultrastructure of human mature oocytes after slow cooling cryopreservation with ethylene glycol. Reproductive BioMedicine Online, 17, 368-377. doi:10.1016/S1472-6483(10)60220-9
[11]	Gook, D.A. and Edgar, D.H. (2007) Human oocyte cryopreservation. Human Reproduction Update, 13, 591-605. doi:10.1093/humupd/dmm028
[12]	Stachecki, J.J., Cohen, J. and Willadsen, S. (1998) Detrimental effects of sodium during mouse oocyte cryopreservation. Biology of Reproduction, 59, 395-400. doi:10.1095/biolreprod59.2.395
[13]	Boldt, J., Cline, D. and McLaughlin, D. (2003) Human oocyte cryopreservation as an adjunct to IVF-embryo transfer cycles. Human Reproduction, 18, 1250-1255. doi:10.1093/humrep/deg242
[14]	Katayama, K.P., Stehlik, J., Kuwayama, M., Kato, O. and Stehlik, E. (2003) High survival rate of vitrified human oocytes results in clinical pregnancy. Fertility and Sterility, 80, 223-224. doi:10.1016/S0015-0282(03)00551-X
[15]	Noyes, N., Porcu, E. and Borini, A. (2009) Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reproductive BioMedicine Online, 18, 769-776. doi:10.1016/S1472-6483(10)60025-9
[16]	Noyes, N., Knopman, J., Labella, P., McCaffrey, C., Clark-Williams, M. and Grifo, J. (2010) Oocyte cryopreservation outcomes including pre-cryo and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes. Fertility and Sterility, 94, 2078-2082. doi:10.1016/j.fertnstert.2010.01.019
[17]	Oktay, K., Cil, A.P. and Bang, H. (2006) Efficiency of oocyte cryopreservation: A meta-analysis. Fertility and Sterility, 86, 70-80. doi:10.1016/j.fertnstert.2006.03.017
[18]	De Melo-Martin, I. and Cholst, I.N. (2008) Researching human oocyte cryopreservation: Ethical issues. Fertility and Sterility, 89, 523-528. doi:10.1016/j.fertnstert.2007.03.039
[19]	Barritt, J., Luna, M., Duke, M. and Copperman, A.B. (2007) Ethical issues surrounding the cryopreservation of human oocytes. Fertility and Sterility, 88, 1016. doi:10.1016/j.fertnstert.2007.07.1365
[20]	Barritt, J., Luna, M., Duke, M., Grunfeld, L., Mukherjee, T., Sandler, B., et al. (2007b) Report of four donor-recipient oocyte cryopreservation cycles resulting in high pregnancy and implantation rates. Fertility and Sterility, 87, 13-17. doi:10.1016/j.fertnstert.2006.04.052
[21]	Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the American Society for Reproductive Medicine (2007) Essential elements of informed consent for elective oocyte cryopreservation: A practice committee opinion. Fertility and Sterility, 88, 1495-1496. doi:10.1016/j.fertnstert.2007.10.009
[22]	Ezcurra, D., Rangnow, J., Craigm M. and Schertzm J. (2008) The HOPE Registry: First US registry for oocyte cryopreservation. Reproductive BioMedicine Online, 17, 743-744. doi:10.1016/S1472-6483(10)60399-9
[23]	Martinuzzi, K. and Copperman, A.B. (2007) Oocyte cryopreservation for elective preservation of reproductive potential. Current Women’s Health Reviews, 3, 209-215. doi:10.2174/157340407781387663
[24]	Eichenlaub-Ritter, U. (1998) Genetics of oocyte ageing. Maturitas, 12, 143-169. doi:10.1016/S0378-5122(98)00070-X
[25]	Tarin, J.J. (1995) Aetiology of age-associated aneuploidy: A mechanism based on the “free radical theory of ageing”. Human Reproduction, 10, 1563-1565.
[26]	Muasher, S.J., Oehninger, S. and Sinometti, S. (1988) The value of basal and/or stimulated serum gonadotrophin levels in prediction of stimulation response and in vitro fertilization outcome. Fertility and Sterility, 50, 298-307.
[27]	Sherman, B.M. and Korenman, S.G. (1975) Hormonal characteristics of the human menstrual cycle throughout reproductive life. Journal of Clinical Investigation, 55, 699-706. doi:10.1172/JCI107979
[28]	Toner, J.P., Philput, C.B., Jones, G.S. and Muasher, S.J. (1991) Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertility and Sterility, 55, 784-791.
[29]	Scott, R.T. and Hofmann, G.E. (1995) Prognostic assessment of ovarian reserve. Fertility and Sterility, 63, 1-11.
[30]	Levi, A.J., Raynault, M.F., Bergh, P.A., Drews, M.R., Miller, B.T. and Scott, R.T. Jr. (2001) Reproductive outcome in patients with diminished ovarian reserve. Fertility and Sterility, 76, 666-669. doi:10.1016/S0015-0282(01)02017-9
[31]	Frattarelli, J.L., Lauria-Costab, D.F., Miller, B.T., Bergh, P.A. and Scott, R.T. (2001) Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertility and Sterility, 75, 834-835.
[32]	Scheffer, G.J., Broekmans, F.J., Dorland, M., Habbema, J.D., Looman, C.W. and Te Velde, E.R. (1999) Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertility and Sterility, 72, 845-851. doi:10.1016/S0015-0282(99)00396-9
[33]	Nahum, R., Shifren, J.L., Chang, Y., Leykin, L., Isaacson, K. and Toth, T.L. (2001) Antral follicle assessment as a tool for predicting outcome in IVF—Is it a better predictor than age and FSH? Journal of Assisted Reproduction and Genetics, 18, 151-155. doi:10.1023/A:1009424407082